About
Overview
Management
Board of Directors
Scientific Advisory Board
Our Science
iNKT Cells
ARDS & Infectious Diseases
Cancer
GvHD
Publications
Platform
Manufacturing
Engineering
Pipeline
Investor & Media
Overview
Press Releases
Events and Presentations
Stock Information
Financials & Filings
Corporate Governance
Careers
Contact
Home
Manufacturing
Manufacturing
MiNK iNKTs Retain Full Activation &
Tumor Cell Killing Throughout Manufacturing
OUR CURRENT MANUFACTURING PROCESS GENERATES UP TO 100BN CELLS WITH RETAINED TUMOR CELL KILLING
